Drug review and approval are the essential functions of a drug regulatory authority. The pharmaceutical industry of a particular market or country depends on the efficient working of drug regulations. It reviews drugs' properties, efficiency, safety, and efficacy against accepted rules and regulations. Depending upon the comparison results, it then allows or disallows a pharma manufacturer to produce that drug in its area of control.
There are various functions and departments that a regulatory authority reviews, such as personal expertise, documentation, equipment, manufacturing facilities, utilities, and other relevant requirements to make its decision. If it finds out that the drug manufacturer has made adequate arrangements for safe and efficient drug manufacturing, the drug regulatory authority permits to production and market of the drug. Otherwise, the pharma manufacturer cannot produce a pharma drug until it completes all the regulatory body requirements.
Why Drug regulatory authority updates their Rules and Regulations
Pharmaceutical regulatory authorities regularly update their rules and regulations regarding drug review and approval. Because pharma industry is constantly evolving, and there are new challenges every time a new dimension is achieved. The changes in the regulatory requirement for drug review and approval cannot be abrupt but requires proper justification and acceptance criteria.
Some ways a regulatory body forms a justification are mentioned below.
Constant research
Regulatory bodies keep an eye on the research conducted by various pharma manufacturing companies. And in some cases, it becomes part of that research. The main reason is to keep itself updated on the latest technological advancement in pharmaceutical drug development and manufacturing. It focuses on areas such as new diseases, the impact of existing technology, or other related factors.
If a regulatory body finds that existing rules and regulations are enough to cope with the present-day challenges, the regulatory body keeps its existing rules unchanged. On the other hand, if it finds out that drug review and approval rules are outdated and fails to fulfill present-day challenges, it tries to update its rules and regulations.
Global pandemic
The global pandemic plays a critical role in reviewing and approving drug regulations. The widespread global pandemic indicates a significant loophole in drug manufacturing and Research companies' ability to fight against the disease. It also indicates weaknesses in pharma organizations' structure, ability, system, research, and expertise. The first step in preparing pharm manufacturing to produce drugs for pandemic, is to develop guidelines that can become effective during a pandemic.
Regulatory bodies keep an eye on the global pandemic to review their guidelines. If pharma companies, following the regulations and guidelines, can tackle and fight the global pandemic, it is assumed regulatory bodies' guidelines are up to date and do not need amendment. If not, these guidelines require more research, clinical trials, investment, and review.
Market recalls
Market recalls referring to the activity where a specific product or batch is called back from the market. This becomes inevitable due to complaints received due to negative feedback from the product user or unusual side effects.
The product effectiveness studies during the clinical trials phase are integral to the drug approval procedure. They are conducted to prevent these side effects, impacts, and recalls.
Product recalls can be due to negligence in implementing quality practices and failure to ensure safety systems. This result in out-of-specification product properties of a product that deviates from the accepted results and effectiveness related to that particular product
But sometimes, this can also result due to failed regulatory regulations.
If there is a product to recall, the pharma drug manufacturer is bound to inform the relevant drug regulatory authority. The main aim is to investigate the recalled product and to study the underlying cause. The drug manufacturer also provides relevant informa...
(All Rights Reserved)